Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evoke Pharma Inc (NASDAQ:EVOK)

3.82
Delayed Data
As of 3:19pm ET
 -0.10 / -2.55%
Today’s Change
2.80
Today|||52-Week Range
8.32
-35.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$24.8M

Company Description

Evoke Pharma, Inc. operates as a pharmaceutical company, which focuses on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. It develops EVK-001a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matt J. D'Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in San Diego, CA.

Contact Information

Evoke Pharma, Inc.
505 Lomas Santa Fe Drive
Solana Beach California 92075
P:(858) 345-1494
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

David A. GonyerPresident, Chief Executive Officer & Director
Marilyn R. CarlsonChief Medical Officer
Matthew J. D'OnofrioSecretary, Treasurer, Chief Business Officer & EVP